| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 202.15B | 201.22B | 188.25B | 214.19B | 199.10B | 159.70B |
| Gross Profit | 30.03B | 29.86B | 28.62B | 29.07B | 26.39B | 22.63B |
| EBITDA | 14.81B | 14.88B | 12.91B | 13.15B | 11.74B | 9.47B |
| Net Income | 18.76B | 18.62B | 16.10B | 6.21B | 6.48B | 7.47B |
Balance Sheet | ||||||
| Total Assets | 248.39B | 257.11B | 259.88B | 232.75B | 229.73B | 224.55B |
| Cash, Cash Equivalents and Short-Term Investments | 15.87B | 24.85B | 18.51B | 13.61B | 14.47B | 17.75B |
| Total Debt | 54.52B | 57.20B | 59.30B | 63.42B | 66.16B | 70.29B |
| Total Liabilities | 115.94B | 123.53B | 126.60B | 126.69B | 129.65B | 130.18B |
| Stockholders Equity | 129.71B | 130.81B | 129.91B | 102.95B | 97.25B | 91.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.66B | 3.83B | 2.53B | 3.26B | 2.64B |
| Operating Cash Flow | 0.00 | 5.00M | 10.49B | 6.15B | 8.77B | 6.04B |
| Investing Cash Flow | 0.00 | 15.10B | 1.92B | -1.62B | -5.86B | 2.25B |
| Financing Cash Flow | 0.00 | -9.23B | -8.45B | -5.93B | -6.57B | -3.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥132.01B | 6.59 | 11.58% | 1.62% | 9.81% | 30.20% | |
68 Neutral | ¥2.54T | 7.93 | 5.18% | 1.98% | 3.15% | -63.65% | |
68 Neutral | ¥215.99B | 16.52 | 6.77% | 2.30% | 8.19% | 34.88% | |
66 Neutral | ¥677.40B | 3.88 | 3.12% | 2.83% | -0.64% | -65.65% | |
66 Neutral | ¥558.97B | 22.37 | 5.02% | 2.12% | -7.98% | -42.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
46 Neutral | ¥16.88B | 1.14 | -111.61% | ― | -11.92% | 61.16% |